Login
$TNDM
$18.80 +$0.32 (1.73%) After hours

$TNDM SEC Filings

Filed On Filing
16 Nov 2026 SCHEDULE 13G/A
16 Nov 2026 SCHEDULE 13G
13 Nov 2026 8-K: Other Events

On November 12, 2026, Tandem Diabetes Care, Inc. (the “Company”) received 510(k) clearance from the U.S. Food and Drug Administration for Tandem Mobi, the world’s first and only tubeless automated insulin delivery system with up to 7 day...

09 Nov 2026 SCHEDULE 13G
05 Nov 2026 10-Q
05 Nov 2026 8-K: Results of Operations and Financial Condition

San Diego, November 5, 2026 - Tandem Diabetes Care, Inc. (Nasdaq: TNDM) (the Company), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended September 30, 2026.

29 Oct 2026 Form 4: Twomey Christopher J, Director

Received 1,700 shares by exercise or conversion ($32.3K) · Sold 1,700 shares ($32.6K)

27 Oct 2026 144
19 Oct 2026 Form 4: Kyrillos Jean-Claude, EVP & Chief Operating Officer

Received 3,637 shares by exercise or conversion · Gave up 1,926 shares to cover exercise price or tax ($31.8K)

17 Sep 2026 144
18 Aug 2026 Form 4: Vosseller Leigh, EVP & CHIEF FINANCIAL OFFICER

Received 4,120 shares by exercise or conversion · Gave up 1,479 shares to cover exercise price or tax ($33.6K)

18 Aug 2026 Form 4: Sheridan John F, Director

Received 15,916 shares by exercise or conversion · Gave up 8,099 shares to cover exercise price or tax ($184K)

18 Aug 2026 Form 4: Morrison Susan, EVP & Chief Admin. Officer

Received 2,827 shares by exercise or conversion · Gave up 809 shares to cover exercise price or tax ($18.4K)

18 Aug 2026 Form 4: Kyrillos Jean-Claude, EVP & Chief Operating Officer

Received 1,010 shares by exercise or conversion · Gave up 535 shares to cover exercise price or tax ($12.2K)

18 Aug 2026 Form 4: Gasser Elizabeth Anne, EVP, Chief Strategy Officer

Received 3,014 shares by exercise or conversion · Gave up 1,618 shares to cover exercise price or tax ($36.8K)

18 Aug 2026 Form 4: Carpenter Rick, EVP & Chief Technology Officer

Received 2,507 shares by exercise or conversion · Gave up 1,277 shares to cover exercise price or tax ($29K)

18 Aug 2026 Form 4: Hansen Shannon Marie, EVP & Chief Legal Officer

Received 3,014 shares by exercise or conversion · Gave up 1,535 shares to cover exercise price or tax ($34.9K)

18 Aug 2026 144
06 Aug 2026 10-Q
06 Aug 2026 8-K: Results of Operations and Financial Condition

San Diego, August 6, 2026 - Tandem Diabetes Care, Inc. (Nasdaq: TNDM) (the Company), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter ended June 30, 2026.

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support